BECK MACK & OLIVER LLC - CANCER GENETICS INC ownership

Quarter-by-quarter ownership
BECK MACK & OLIVER LLC ownership history of CANCER GENETICS INC
ValueSharesWeighting
Q2 2016$36,000
-35.7%
18,225
-7.1%
0.00%
-50.0%
Q1 2016$56,000
-13.8%
19,6250.0%0.00%0.0%
Q4 2015$65,000
-60.1%
19,625
+8.6%
0.00%
-50.0%
Q3 2014$163,000
-21.6%
18,075
-1.6%
0.00%
-20.0%
Q2 2014$208,000
-24.9%
18,3750.0%0.01%
-16.7%
Q1 2014$277,000
+11.2%
18,375
+1.5%
0.01%0.0%
Q4 2013$249,000
-6.0%
18,100
+38.2%
0.01%
-14.3%
Q3 2013$265,000
+103.8%
13,1000.0%0.01%
+75.0%
Q2 2013$130,00013,1000.00%
Other shareholders
CANCER GENETICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 1,391,607$1,239,0000.75%
PERKINS CAPITAL MANAGEMENT INC 1,004,550$894,0000.64%
Fairbanks Capital Management, Inc. 234,170$208,0000.24%
DIKER MANAGEMENT LLC 64,365$57,0000.02%
Granahan Investment Management 276,417$246,0000.02%
WEDBUSH SECURITIES INC 52,310$47,0000.01%
Court Place Advisors, LLC 10,000$9,0000.00%
SeaCrest Wealth Management, LLC 11,000$10,0000.00%
Renaissance Technologies 1,068,700$1,317,0000.00%
PANAGORA ASSET MANAGEMENT INC 43,664$39,0000.00%
View complete list of CANCER GENETICS INC shareholders